GE Healthcare Announces FDA Approval Of SenoClaire, New Breast Imaging Eith 3D Tomosynthesis Solution

By: via Benzinga
GE Healthcare (NYSE: GE) today announced the FDA approval of SenoClaire*, GE's new breast tomosynthesis solution designed with a ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.